Broadwood Partners, L.P. - Director, 10%+ Owner at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Broadwood Partners, L.P. - trading volume in the past year for Lineage Cell Therapeutics, Inc.

Holdings reported by Broadwood Partners, L.P. for Lineage Cell Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 41.7M $43.3M $1.04 Feb 6, 2024 Direct
Common Shares 41.7M $43.3M $1.04 Feb 6, 2024 Indirect

Transactions reported by Broadwood Partners, L.P. for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.